Balance Dimensions-Based Rehabilitation Program in People With Acquired Brain Injury

The purpose of this clinical trial is to find out whether a rehabilitation program based on different dimensions of balance can improve balance, mobility, walking ability, and quality of life in people with acquired brain injury. The main questions this study aims to answer are: * Does this rehabilitation program improve balance? * Does it improve mobility and walking ability? * Does it reduce the risk of falls? * Does it improve quality of life? Researchers will compare a specific balance rehabilitation program with conventional physiotherapy to determine whether the balance program provides additional benefits. Participants with acquired brain injury who meet the eligibility criteria will be randomly assigned to one of two groups. Both groups will receive treatment for 12 weeks. Participants will: * Complete balance and mobility assessments before starting treatment. * Receive either the balance rehabilitation program or conventional physiotherapy five times per week. * Complete assessments immediately after treatment and again 6 and 12 weeks later. The information obtained from this study may help improve rehabilitation programs and daily functioning for people with acquired brain injury.

Inclusion Criteria: * Adults aged 18 to 65 years. * Diagnosis of acquired brain injury (stroke, traumatic brain injury, anoxic brain injury, brain tumor, or encephalitis). * At least 2 months since the brain injury. * Mini-Mental State Examination (MMSE) score greater than 24. * Modified Rankin Scale (mRS) score of 3 or lower. * Ability to walk independently or with an assistive device. * Clinical stability and ability to participate in a rehabilitation program. * Written informed consent signed by the participant. Exclusion Criteria: * Severe cognitive impairment (MMSE score of 24 or lower). * Severe functional dependence (mRS score greater than 3). * Unstable medical conditions that may interfere with participation. * Severe musculoskeletal, cardiovascular, or other conditions that prevent safe participation in the intervention. * Severe communication disorders that prevent understanding of study procedures. * Participation in another clinical trial that may interfere with the study results.